January 27, 2020 -Clinical Synopsis
Patient Condition: 74 year old female with a venous leg ulcer for longer than 5 months and confirmed hemangioma. Prior to her referral to the wound specialty team at Lions Gate Hospital, Vancouver Coastal Health for stalled wound healing, the patient had received multiple courses of oral antibiotics,
… Read MoreJanuary 27, 2020 -ABSTRACT Aim:
To assess the effectiveness of the MolecuLight i:X Imaging Device in the management of bacterial load in burns patients.
Method:30 burns patients were imaged at various points during their treatment (during dressing changes) using the MolecuLight camera.
Results/Discussion:30 patients were photographed. 12 did not
… Read MoreJanuary 27, 2020 -ABSTRACT Aim:
Real-time, point-of-care detection of critical bacterial colonization relies primarily on visual inspection and clinical signs and symptoms. Fluorescence imaging has recently been used to detect bacterial fluorescence in wounds at the bedside.1 This pilot study aimed to assess its effects on clinician decisions and patient care.
… Read More
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
©2026
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.